TFF Pharmaceuticals, Inc. (TFFP)

TFF Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-19.93	-21.24	-31.77	-31.04	-18.57	-36.68
Depreciation & Amortization	0.52	0.5	0.39	0.11	0	0
Share-Based Compensation	2.8	2.93	4.25	3.55	2.19	0.59
Other Operating Activities	1.79	1.78	-0.21	-2.18	-0.24	0.06
Operating Cash Flow	-14.82	-16.04	-27.34	-29.56	-16.62	-11.22
Capital Expenditures	-0.09	-0.09	-1.55	-0.87	-1.1	0
Investing Cash Flow	-0.09	-0.09	-1.55	-0.87	-1.1	0
Share Issuance / Repurchase	5.93	5.01	11.75	28.88	24.99	21.85
Other Financing Activities	-	-	-	-	-	7.2
Financing Cash Flow	5.93	5.01	11.75	28.88	24.99	29.05
Exchange Rate Effect	-0.03	-0.01	-0.04	0.03	-0.07	0
Net Cash Flow	-9	-11.13	-17.18	-1.51	7.21	17.83
Free Cash Flow	-14.91	-16.13	-28.89	-30.43	-17.72	-11.22
Free Cash Flow Margin	-1683.55%	-2198.34%	-5827.59%	-34511.26%	-	-
Free Cash Flow Per Share	-6.25	-9.00	-24.09	-30.64	-21.69	-40.61

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).